Chicago Research Center is seeking participants for an ESKETAMINE depression clinical trial. Receive access to 3-months worth of the ground-breaking, fast-acting treatment FREE OF CHARGE (single dose goes for over $1000 at public clinics). Designed for treatment-resistant depression, skip the hassle of daily antidepressants with weekly nasal-spray dosing. While the pandemic may be out of control, your mental health shouldn't be. CRC is here to make your well-bring our priority.
You may qualify if:
-You are aged 18+
-You are currently suffering from depressive symptoms.
-You have tried and failed on a minimum of TWO (2) antidepressant medications (verification required).
-You may be eligible regardless of whether or not you're taking medication to treat depression.
If you qualify and enroll:
-All study related medical care and study medication will be provided at no cost (no insurance needed).
-You will be compensated for your time, $75 per visit.
-Free travel assistance is available to and from our clinic.
If you are interested, please fill out our brief survey to have a staff member contact you to see if you may qualify:
https://www.surveymonkey.com/r/L9BRT29 - (you may have to copy and paste the link into your browser)
Chicago Research Center
https://www.chicagoresearchcenter.com/
Discussion
By posting you agree to the Terms and Privacy Policy.